Brief: Janone Advances Toward Initiation Of Phase 2B Peripheral Artery Disease Trial For Lead Product Candidate JAN101
June 8 (Reuters) - Janone Inc JAN.O :
* JANONE ADVANCES TOWARD INITIATION OF PHASE 2B PERIPHERAL
ARTERY
DISEASE (PAD) TRIAL FOR LEAD PRODUCT CANDIDATE JAN101
Source text for Eikon: urn:newsml:reuters.com:*:nPn5YspqMa
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsCorrected: UPDATE 1-Trump-linked fintech firm AI Financial sells unit to PrimeDelta
Trump-linked fintech AI Financial sells unit to Prime Delta
Perpetuals.com ends acquisition talks with Trump-linked crypto firm
Brief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q